09 May 2023 --- New research published in BMC Medicine has identified a novel mechanism whereby sodium-5,6-benzylidene-L-ascorbate (SBA) and short-chain fatty acids (SCFAs) metabolites mediate the effects of MK-7 on glucose metabolism and insulin sensitivity in Type 2 diabetics. MK-7 is the most bioavailable form of vitamin K2 and is also naturally produced in the gut.
